Bridge to Life

United States · Healthtech

Makes organ preservation and perfusion technology for liver transplants

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series C+Debt$110MLauxera Capital Partners — Role not disclosedSoleus Capital — Role not disclosedSoleus Capital Credit Opportunities Fund — Role not disclosed
Sourcesbridgetolife.com ↗